سند علمی

Revisions in the International System for Staging Lung Cancer.

چکیده

Revisions in stage grouping of the TNM subsets (T=primary tumor, N=regional lymph nodes, M=distant metastasis) in the International System for Staging Lung Cancer have been adopted by the American Joint Committee on Cancer and the Union Internationale Contre le Cancer. These revisions were made to provide greater specificity for identifying patient groups with similar prognoses and treatment options with the least disruption of the present classification: T1N0M0, stage IA; T2N0M0, stage IB; T1N1M0, stage IIA; T2N1M0 and T3N0M0, stage IIB; and T3N1M0, T1N2M0, T2N2M0, T3N2M0, stage IIIA. The TNM subsets in stage IIIB-T4 any N M0, any T N3M0, and in stage IV-any T any N M1, remain the same. Analysis of a collected database representing all clinical, surgical-pathologic, and follow-up information for 5,319 patients treated for primary lung cancer confirmed the validity of the TNM and stage grouping classification schema.

اسناد مشابه

  • The revised tumor-node-metastasis staging system for lung cancer: changes and perspectives.

    سند علمی۲۰۱۰Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e TisilogiaFilipe Moreira de Andrade, Omar Moté Abou Mourad, Luiz Felippe Judice

    The tumor-node-metastasis (TNM) staging system for lung cancer has been modified since its first edition in the late 1960s. Its seventh edition has been recently published and, for the first time, a truly worldwide database was analyzed in order to propose modifications in the st

  • The revised TNM staging system for lung cancer.

    سند علمی۲۰۰۹Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of AsiaRamon Rami-Porta, John J Crowley, Peter Goldstraw

    The International Staging Committee (ISC) of the International Association for the Study of Lung Cancer (IASLC) collected 68,463 patients with nonsmall cell lung cancer and 13,032 patients with small cell lung cancer, registered or diagnosed from 1990 to 2000, whose records had a

  • Evaluation of the 7th and 8th editions of the AJCC/UICC TNM staging systems for lung cancer in a large North American cohort

    سند علمی۲۰۱۷OncotargetLin Yang, Shidan Wang, Yunyun Zhou, Sunny Lai

    PURPOSE The new 8th American Joint Committee on Cancer (AJCC)/International Union for Cancer Control (UICC) lung cancer staging system was developed and internally validated using the International Association for the Study of Lung Cancer (IASLC) database, but external validation

  • The seventh tumour–node–metastasis staging system for lung cancer: Sequel or prequel?

    سند علمی۲۰۱۳EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]Jan P. van Meerbeeck, Annelies Janssens

    Anatomical cancer extent is an important predictor of prognosis and determines treatment choices. In non-small-cell lung cancer (NSCLC) the tumour-node-metastasis (TNM) classification developed by Pierre Denoix replaced in 1968 the Veterans Administration Lung cancer Group (VALG)

  • Early Stage Lung Cancer Detection in Systemic Sclerosis Does Not Portend Survival Benefit: A Cross Sectional Study

    سند علمی۲۰۱۵PloS oneJeremy B. Katzen, Kirtee Raparia, Rishi Agrawal, Jyoti D. Patel

    BACKGROUND Systemic Sclerosis (SSc) is a rare connective tissue disorder associated with an increased risk of malignancy including lung cancer. METHODS A single center review of all cases of lung cancer in patients with SSc was conducted. Clinical, radiographic, and detailed path

  • Value of the new TNM staging system for lung cancer.

    سند علمی۱۹۸۹ChestC F Mountain

    CHEST I 96 11 I JULY, 1989 I Supplement 47S 32 Cohen AM, Creviston S, LiPuma JP, Bryan PJ, et al. Nuclear magnetic resonance imaging of the mediastinum and hila: early impressions of its efficacy. AJR 1983; 141:1163-69 33 Gamsu C, Webb WR, Sheldon P, Kaufman L, et al. Nuclear mag